Skip to main content
Log in

High preoperative neutrophil–lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the association between preoperative neutrophil–lymphocyte ratio (NLR) and oncological outcomes in patients with localized prostate cancer (PCa) after radical prostatectomy (RP).

Methods

We retrospectively reviewed the records of 1367 patients who underwent RP between November 2003 and April 2012. Patients who underwent a concurrent biopsy/procedure in other organs, had evidence of acute infection, or had systemic inflammatory disease were excluded. We divided the patients by NLR level and analyzed their perioperative outcomes. To determine NLR significance, we performed a multivariate logistic regression analysis of the pathological adverse outcomes and a Cox proportional hazard analysis of the biochemical recurrence (BCR), which was defined as a prostate-specific antigen level ≥0.2 ng/mL on two consecutive tests.

Results

Among the 1367 patients, 158 (11.6 %) in the high-NLR (≥2.5) group had a higher biopsy Gleason score (p < 0.001), pathological Gleason score (p < 0.001), and pathological stage (p < 0.001) than patients in the low-NLR (<2.5) group (n = 1209, 88.4 %). Multivariate analysis revealed that high NLR was significantly correlated with adverse pathological outcomes of higher pathological stage (HR 1.688; 95 % CI 1.142–2.497; p = 0.009) and extracapsular extension (HR 1.698; 95 % CI 1.146–2.516; p = 0.008). Kaplan–Meier analysis showed significantly worse BCR-free survival (p < 0.001) in patients with a high NLR. A high NLR was a significant predictor of BCR after RP (HR 1.358; 95 % CI 1.008–1.829; p = 0.044).

Conclusions

High NLR was significantly related to unfavorable clinicopathological outcomes and worse BCR-free survival. Further studies are needed to clarify the correlation between NLR and PCa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29

    Article  PubMed  Google Scholar 

  2. Sfanos KS, De Marzo AM (2012) Prostate cancer and inflammation: the evidence. Histopathology 60:199–215

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mimeault M, Batra SK (2013) Development of animal models underlining mechanistic connections between prostate inflammation and cancer. World J Clin Oncol 4:4–13

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137:425–428

    Article  PubMed  Google Scholar 

  5. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181–184

    Article  CAS  PubMed  Google Scholar 

  6. Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, Ress AL et al (2013) Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109:416–421

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Shimada H, Takiguchi N, Kainuma O, Soda H, Ikeda A, Cho A et al (2010) High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13:170–176

    Article  PubMed  Google Scholar 

  8. Nuhn P, Vaghasia AM, Goyal J, Zhou XC, Carducci MA, Eisenberger MA et al (2014) Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel. BJU Int 114:E11–E17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Leibowitz-Amit R, Templeton AJ, Omlin A, Pezaro C, Atenafu EG, Keizman D et al (2014) Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer. Ann Oncol 25:657–662

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Gazel E, Tastemur S, Acikgoz O, Yigman M, Olcucuoglu E, Camtosun A et al (2015) Importance of neutrophil/lymphocyte ratio in prediction of PSA recurrence after radical prostatectomy. Asian Pac J Cancer Prev 16:1813–1816

    Article  PubMed  Google Scholar 

  11. Langsenlehner T, Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Gerger A et al (2015) Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. World J Urol [Epub ahead of print]

  12. Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D’Amico AV, Dmochowski RR et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540–545

    Article  CAS  PubMed  Google Scholar 

  13. Hong SK, Lee ST, Kim SS, Min KE, Byun SS, Cho SY et al (2009) Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer. Prostate 69:820–826

    Article  CAS  PubMed  Google Scholar 

  14. Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG (2015) Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol 21:2807–2815

    Article  PubMed  PubMed Central  Google Scholar 

  15. Galizia G, Lieto E, Zamboli A, De Vita F, Castellano P, Romano C et al (2015) Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis. Surgery 158:112–120

    Article  PubMed  Google Scholar 

  16. Cho JS, Park MH, Ryu YJ, Yoon JH (2015) The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer. Ann Surg Treat Res 88:187–192

    Article  PubMed  PubMed Central  Google Scholar 

  17. Sonpavde G, Pond GR, Armstrong AJ, Clarke SJ, Vardy JL, Templeton AJ et al (2014) Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer. Clin Genitourin Cancer 12:317–324

    Article  PubMed  Google Scholar 

  18. De Larco JE, Wuertz BRK, Furcht LT (2004) The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 10:4895–4900

    Article  PubMed  Google Scholar 

  19. Neveu B, Moreel X, Deschênes-Rompré MP, Bergeron A, LaRue H, Ayari C et al (2014) IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness. Res Rep Urol 6:27–34

    PubMed  PubMed Central  Google Scholar 

  20. Caruso DJ, Carmack AJ, Lokeshwar VB, Duncan RC, Soloway MS, Lokeshwar BL (2008) Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence. Clin Cancer Res 14:4111–4118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Vesely MD, Schreiber RD (2013) Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy. Ann NY Acad Sci 1284:1–5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 105:93–103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203–213

    Article  CAS  PubMed  Google Scholar 

  24. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F et al (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102:18538–18543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ege H, Gertz MA, Markovic SN, Lacy MQ, Dispenzieri A, Hayman SR et al (2008) Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study. Br J Haematol 141:792–798

    Article  CAS  PubMed  Google Scholar 

  26. Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG et al (2007) Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 97:1266–1270

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author contributions

Hakmin Lee and Jong Jin Oh involved in conception and design of study. Hakmin Lee, Seong Jin Jeong, Seok-Soo Byun, Sang Eun Lee, and Sung Kyu Hong contributed to acquisition of data. Hakmin Lee, Seong Jin Jeong, Seok-Soo Byun, Sang Eun Lee, and Sung Kyu Hong performed statistical analysis and interpreted the data. Hakmin Lee and Jong Jin Oh drafted the manuscript. Hakmin Lee, Jong Jin Oh, Seok-Soo Byun, and Sang Eun Lee revised the manuscript with intellectual criticism. And all authors approved the final version of the manuscript to be published.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jong Jin Oh.

Ethics declarations

Ethical standard

The study was reviewed and approved by two ethical review boards of both involved institutions. Methods were carried out in accordance with the approved guidelines.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, H., Jeong, S.J., Hong, S.K. et al. High preoperative neutrophil–lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy. World J Urol 34, 821–827 (2016). https://doi.org/10.1007/s00345-015-1701-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-015-1701-6

Keywords

Navigation